Evidence map›Paper›PMID 28522948›Full record

ArticleIntestinal research2017

Evaluation of Xpert MTB/RIF assay performance in the diagnosis of abdominal tuberculosis.

Suraj Kumar, Sawan Bopanna, Saurabh Kedia, Pratap Mouli, Rajan Dhingra, Rajesh Padhan, Mikashmi Kohli, Jigyasa Chaubey, Rohini Sharma, Prasenjit Das and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Intestinal research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. XpertThe Cochrane database of systematic reviews · 2018
    Pooled it
  5. Gastrointestinal tuberculosis: A systematic review of epidemiology, presentation, diagnosis and treatment.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Pooled it
  6. Review
  7. Non-celiac Enteropathies.Current gastroenterology reports · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  19. Apoptosis in peripheral blood lymphocytes in intestinal tuberculosis and Crohn's disease: Implications to diagnostic differentiation.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2020
    Article
  20. Abdominal Tuberculosis Mimicking Ovarian Cancer: A Diagnostic Dilemma.Journal of obstetrics and gynaecology of India · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Suraj KumarDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Sawan BopannaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Saurabh KediaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Pratap MouliDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Rajan DhingraDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Rajesh PadhanDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Mikashmi KohliDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Jigyasa ChaubeyDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Rohini SharmaDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Prasenjit DasDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.
S DattaguptaDepartment of Pathology, All India Institute of Medical Sciences, New Delhi, India.
Govind MakhariaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
S K SharmaDepartment of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Vineet AhujaDepartment of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
All India Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsThe use of genetic probes for the diagnosis of pulmonary tuberculosis (TB) has been well described. However, the role of these assays in the diagnosis of intestinal tuberculosis is unclear. We therefore assessed the diagnostic utility of the Xpert

methodsOf 99 patients recruited, 37 had intestinal TB; two control groups comprised 43 with Crohn's disease (CD) and 19 with irritable bowel syndrome. Colonoscopy was performed before starting any therapy; mucosal biopsies were subjected to histopathology, acid-fast bacilli staining, Lowenstein-Jensen culture, and nucleic acid amplification testing using the Xpert MTB/RIF assay. Patients were followed up for 6 months to confirm the diagnosis and response to therapy. A composite reference standard was used for diagnosis of TB and assessment of the diagnostic utility of the Xpert MTB/RIF assay.

resultsOf 37 intestinal TB patients, the Xpert MTB/RIF assay was positive in three of 37 (8.1%), but none had MDR-TB. The sensitivity, specificity, positive predictive value, and negative predictive value of the Xpert MTB/RIF assay was 8.1%, 100%, 100%, and, 64.2%, respectively.

conclusionsThe Xpert MTB/RIF assay has low sensitivity but high specificity for intestinal TB, and may be helpful in endemic tuberculosis areas, when clinicians are faced with difficulty differentiating TB and CD. Based on the Xpert MTB/RIF assay, the prevalence of intestinal MDR-TB is low in the Indian population.

Indexed as

Crohn diseaseTuberculosis, multidrug-resistantXpert MTB/RIF assay

Identifiers

PMID28522948
PMCPMC5430010
OpenAlexW2612813198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.